Fig. 7
From: Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
MYH9 as an unfavorable factor in gliomas. RT-qPCR analysis of MYH9 mRNA expression in 15 glioma tissues and 15 para-tumor tissues. (B) IHC score of MYH9 in (gradeI-IV) glioma tissues. (C, D) Kaplan–Meier survival analysis for overall survival (C) and Progression Free survival (D) in TMA showing MYH9 expression. Data are presented as the mean ± SD for three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001